Pro Dex (PDEX) Shares Outstanding (Diluted Average) (2010 - 2026)
Pro Dex's (PDEX) quarterly Shares Outstanding (Diluted Average) came in at $3.3 million in Q1 2026, down 1.9% year-on-year from $3.4 million in Q1 2025, and little changed quarter-over-quarter from $3.3 million in Q4 2025.
Pro Dex (PDEX) Shares Outstanding (Diluted Average) (2010 - 2026) Analysis & Trends
Pro Dex has disclosed Shares Outstanding (Diluted Average) across 16 years of filings, most recently posting $3.3 million for Q1 2026.
- Shares Outstanding (Diluted Average) for Q1 2026 came in at $3.3 million, down 1.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.3 million (down 1.9% YoY), and the FY2025 annual result was $3.4 million, down 5.88% from the prior year.
- Shares Outstanding (Diluted Average) came in at $3.3 million for Q1 2026 at Pro Dex, roughly flat from $3.3 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $3.7 billion in Q1 2022 to a low of $3656.0 in Q1 2023.
- The 5-year median for Shares Outstanding (Diluted Average) is $3.5 million (2024), against an average of $442.9 million.
- Across the five-year window, Shares Outstanding (Diluted Average) slumped 100.0% in 2023 and surged 96284.66% in 2024, its largest moves.
- Pro Dex's Shares Outstanding (Diluted Average) stood at $3.7 million in 2022, then slipped by 1.1% to $3.6 million in 2023, then slipped by 6.45% to $3.4 million in 2024, then declined by 2.21% to $3.3 million in 2025, then dropped by 0.06% to $3.3 million in 2026.
- The last three Shares Outstanding (Diluted Average) figures came in at $3.3 million (Q1 2026), $3.3 million (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 359.80 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 824.84 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 145.72 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 72.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 175.50 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 195.00 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 71.61 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 515.00 Mn |
| 10 | Pro Dex | 200.16 Mn | 192.54 Mn | 6.13 Mn | 3.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.30 Mn |
| Dec 31, 2025 | 3.30 Mn |
| Sep 30, 2025 | 3.34 Mn |
| Jun 30, 2025 | 3.36 Mn |
| Mar 31, 2025 | 3.37 Mn |
| Dec 31, 2024 | 3.38 Mn |
| Sep 30, 2024 | 3.29 Mn |
| Jun 30, 2024 | 3.57 Mn |
| Mar 31, 2024 | 3.52 Mn |
| Dec 31, 2023 | 3.61 Mn |
| Sep 30, 2023 | 3.55 Mn |
| Jun 30, 2023 | 3.64 Mn |
| Mar 31, 2023 | 3,656.00 |
| Dec 31, 2022 | 3.65 Mn |
| Sep 30, 2022 | 3.69 Mn |
| Jun 30, 2022 | 3.73 Bn |
| Mar 31, 2022 | 3.75 Bn |
| Dec 31, 2021 | 3.77 Bn |
| Sep 30, 2021 | 3.78 Bn |
| Jun 30, 2021 | 3.80 Bn |